Product Information
SOD SULFACE-SULF 9.8-4.8% CLSR is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.1306 per GM under NDC 69367024410. Its NADAC has been published 311 times since Oct 21, 2020.
Strength
98; 48 mg/g; mg/g
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367024410
Classification
Generic
Dosage Form
LIQUID
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
SULFACETAMIDE SODIUM; SULFURApproval Type
Unapproved
On Market Since
5/5/2020
Pharmacological Classes
Price Statistics
The NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has been published 311 times since Oct 21, 2020, and over the history we have for it it has declined 80.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1306 per GM |
|---|---|
| All-time high | $0.9302 (Jan 10, 2024) |
| All-time low | $0.1240 (Apr 22, 2026) |
| 52-week high | $0.1942 |
| 52-week low | $0.1240 |
| Median price | $0.5459 |
| Average price | $0.5078 |
| Largest weekly change | +51.7% (May 17, 2023) |
| Weeks tracked | 311 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the sulfacetamide sodium and sulfur market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Westminster Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sulfacetamide sodium and sulfur market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOD SULFACE-SULF 9.8-4.8% CLSR?
The current National Average Drug Acquisition Cost (NADAC) for SOD SULFACE-SULF 9.8-4.8% CLSR, manufactured by Westminster Pharmaceuticals LLC, is $0.1306 per GM (NDC 69367024410), effective Sep 30, 2026.
How has the price of SOD SULFACE-SULF 9.8-4.8% CLSR changed over time?
Over the history we have for it, the NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has declined 80.9%. It has been tracked across 311 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for SOD SULFACE-SULF 9.8-4.8% CLSR?
Since Oct 21, 2020, the NADAC for SOD SULFACE-SULF 9.8-4.8% CLSR has ranged from a low of $0.1240 (Apr 22, 2026) to a high of $0.9302 (Jan 10, 2024), with a median of $0.5459 per GM.
Are there cheaper alternatives to SOD SULFACE-SULF 9.8-4.8% CLSR?
No other NADAC-published product currently shares the active ingredient and strength of SOD SULFACE-SULF 9.8-4.8% CLSR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SOD SULFACE-SULF 9.8-4.8% CLSR?
SOD SULFACE-SULF 9.8-4.8% CLSR (NDC 69367024410) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.